Pilar Manrique
Senior Scientist & Head of Production Microviable Therapeutics
Pilar obtained her undergraduate degree in Biotechnology at Universidad Francisco de Vitoria (2009) and her doctorate at Montana State University (2018).
Pilar has worked over ten years studying the human gut microbiome. Her research has studied the role of human gut bacteriophages in health and disease and the impact of bacteriophages in the success of fecal microbiota transplant treatment. Moreover, during her postdoc at Ohio State University, she studied the influence of the gut microbiome on the recovery from central nervous system injury.
Pilar joined Microviable Therapeutics in 2022 as Research Scientist to support the R&D area. Over the last three years Pilar has contributed to R&D of novel products, and has led the development of MVT-201, including generation of in vivo preclinical data and scaling studies for manufacturing under GMP conditions, necessary to enter Clinical Studies.
Seminars
- Showcase a proprietary manufacturing process that isolates microbial fractions while discarding faecal material
- Present preclinical data in infectious disease, melanoma, and colorectal cancer models
- Prepare for IND submission and clinical trial initiation to validate cross-indication potential
